Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells

G. Camussi, E. Turello, F. Bussolinoc, Corrado Baglioni

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Treatment of human umbilical cord vein endothelial cells with tumor necrosis factor results in marked changes in cell shape and cytoskeletal organization. After 4 h of treatment, these cells loose reciprocal contacts with the formation of intercellular gaps. This retraction reaches a maximum after 6 h when most stress fibers staining for F-actin disappear and vinculin becomes diffused in the cytoplasm. Such changes spontaneously reverse after 24 h in the presence of tumor necrosis factor or after 2 h of incubation in fresh medium. After treatment with tumor necrosis factor, endothelial monolayers become permeable to albumin because of gaps that form between cells. Normal human serum, plasma ±-proteinase inhibitor and an anti-inflammatory peptide that decrease synthesis of platelet-activating factor inhibit the changes induced by tumor necrosis factor. Furthermore, receptor antagonists of platelet-activating factor have the same effect.These findings suggest that platelet-activating factor is a secondary mediator responsible for the changes in ceil shapeand cytoskeletal organization, and for the leakiness of endothelial monolayers.

Original languageEnglish
Pages (from-to)84-91
Number of pages8
JournalInternational Archives of Allergy and Immunology
Volume96
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Endothelial Cells
Tumor Necrosis Factor-alpha
Platelet Activating Factor
Vinculin
Stress Fibers
Cell Shape
Umbilical Cord
Human Umbilical Vein Endothelial Cells
Actins
Albumins
Cytoplasm
Peptide Hydrolases
Anti-Inflammatory Agents
Staining and Labeling
Peptides
Serum

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. / Camussi, G.; Turello, E.; Bussolinoc, F.; Baglioni, Corrado.

In: International Archives of Allergy and Immunology, Vol. 96, No. 1, 1991, p. 84-91.

Research output: Contribution to journalArticle

@article{81c7b91dffff48b6a218eed5927e52b8,
title = "Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells",
abstract = "Treatment of human umbilical cord vein endothelial cells with tumor necrosis factor results in marked changes in cell shape and cytoskeletal organization. After 4 h of treatment, these cells loose reciprocal contacts with the formation of intercellular gaps. This retraction reaches a maximum after 6 h when most stress fibers staining for F-actin disappear and vinculin becomes diffused in the cytoplasm. Such changes spontaneously reverse after 24 h in the presence of tumor necrosis factor or after 2 h of incubation in fresh medium. After treatment with tumor necrosis factor, endothelial monolayers become permeable to albumin because of gaps that form between cells. Normal human serum, plasma ±-proteinase inhibitor and an anti-inflammatory peptide that decrease synthesis of platelet-activating factor inhibit the changes induced by tumor necrosis factor. Furthermore, receptor antagonists of platelet-activating factor have the same effect.These findings suggest that platelet-activating factor is a secondary mediator responsible for the changes in ceil shapeand cytoskeletal organization, and for the leakiness of endothelial monolayers.",
author = "G. Camussi and E. Turello and F. Bussolinoc and Corrado Baglioni",
year = "1991",
doi = "10.1159/000235539",
language = "English",
volume = "96",
pages = "84--91",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells

AU - Camussi, G.

AU - Turello, E.

AU - Bussolinoc, F.

AU - Baglioni, Corrado

PY - 1991

Y1 - 1991

N2 - Treatment of human umbilical cord vein endothelial cells with tumor necrosis factor results in marked changes in cell shape and cytoskeletal organization. After 4 h of treatment, these cells loose reciprocal contacts with the formation of intercellular gaps. This retraction reaches a maximum after 6 h when most stress fibers staining for F-actin disappear and vinculin becomes diffused in the cytoplasm. Such changes spontaneously reverse after 24 h in the presence of tumor necrosis factor or after 2 h of incubation in fresh medium. After treatment with tumor necrosis factor, endothelial monolayers become permeable to albumin because of gaps that form between cells. Normal human serum, plasma ±-proteinase inhibitor and an anti-inflammatory peptide that decrease synthesis of platelet-activating factor inhibit the changes induced by tumor necrosis factor. Furthermore, receptor antagonists of platelet-activating factor have the same effect.These findings suggest that platelet-activating factor is a secondary mediator responsible for the changes in ceil shapeand cytoskeletal organization, and for the leakiness of endothelial monolayers.

AB - Treatment of human umbilical cord vein endothelial cells with tumor necrosis factor results in marked changes in cell shape and cytoskeletal organization. After 4 h of treatment, these cells loose reciprocal contacts with the formation of intercellular gaps. This retraction reaches a maximum after 6 h when most stress fibers staining for F-actin disappear and vinculin becomes diffused in the cytoplasm. Such changes spontaneously reverse after 24 h in the presence of tumor necrosis factor or after 2 h of incubation in fresh medium. After treatment with tumor necrosis factor, endothelial monolayers become permeable to albumin because of gaps that form between cells. Normal human serum, plasma ±-proteinase inhibitor and an anti-inflammatory peptide that decrease synthesis of platelet-activating factor inhibit the changes induced by tumor necrosis factor. Furthermore, receptor antagonists of platelet-activating factor have the same effect.These findings suggest that platelet-activating factor is a secondary mediator responsible for the changes in ceil shapeand cytoskeletal organization, and for the leakiness of endothelial monolayers.

UR - http://www.scopus.com/inward/record.url?scp=0025997208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025997208&partnerID=8YFLogxK

U2 - 10.1159/000235539

DO - 10.1159/000235539

M3 - Article

C2 - 1752699

AN - SCOPUS:0025997208

VL - 96

SP - 84

EP - 91

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 1

ER -